Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Immune phenotype of children with newly diagnosed and gluten-free diet-treated celiac disease.

Cseh Á, Vásárhelyi B, Szalay B, Molnár K, Nagy-Szakál D, Treszl A, Vannay Á, Arató A, Tulassay T, Veres G.

Dig Dis Sci. 2011 Mar;56(3):792-8. doi: 10.1007/s10620-010-1363-6. Epub 2010 Aug 5.

PMID:
20683660
2.

Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.

Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Vossenkaemper A, Rovedatti L, Leakey NA, Croft NM, Troncone R, Corazza GR, Stagg AJ, Monteleone G, MacDonald TT.

Gastroenterology. 2007 Oct;133(4):1175-87. Epub 2007 Aug 14.

PMID:
17919493
3.

Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.

Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Assunta B, Plantone D, Cammarota G, Tonali PA, Batocchi AP.

Hum Immunol. 2009 Jun;70(6):430-5. doi: 10.1016/j.humimm.2009.04.006. Epub 2009 Apr 11.

PMID:
19364517
4.

Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease?

Lähteenoja H, Toivanen A, Viander M, Räihä I, Rantala I, Syrjänen S, Mäki M.

Scand J Immunol. 2000 Dec;52(6):602-8.

5.

Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.

Batoulis H, Addicks K, Kuerten S.

Ann Anat. 2010 Aug 20;192(4):179-93. doi: 10.1016/j.aanat.2010.06.006. Epub 2010 Jul 15. Review. Erratum in: Ann Anat. 2011 Feb 20;193(1):76-7.

PMID:
20692821
6.

Natural killer cell activity in celiac disease in children on a gluten-free diet and after gluten challenge.

Arató A, Kósnai I, Gergely P.

J Pediatr. 1988 Jan;112(1):44-6. No abstract available.

PMID:
3335960
7.

Infiltration of Foxp3- and Toll-like receptor-4-positive cells in the intestines of children with food allergy.

Westerholm-Ormio M, Vaarala O, Tiittanen M, Savilahti E.

J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):367-76. doi: 10.1097/MPG.0b013e3181cd2636.

PMID:
20216098
8.

Celiac disease: from pathogenesis to novel therapies.

Schuppan D, Junker Y, Barisani D.

Gastroenterology. 2009 Dec;137(6):1912-33. doi: 10.1053/j.gastro.2009.09.008. Epub 2009 Sep 18. Review.

PMID:
19766641
9.

Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage between memory function, gut homing and Th1 polarization.

Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I.

J Leukoc Biol. 2006 Apr;79(4):676-85. Epub 2006 Jan 13.

PMID:
16415168
10.

Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment.

Romaldini CC, Barbieri D, Okay TS, Raiz R Jr, Cançado EL.

J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):513-7.

PMID:
12394376
11.

Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.

Szebeni B, Veres G, Dezsofi A, Rusai K, Vannay A, Bokodi G, Vásárhelyi B, Korponay-Szabó IR, Tulassay T, Arató A.

J Pediatr Gastroenterol Nutr. 2007 Aug;45(2):187-93.

PMID:
17667714
12.

Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.

de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J.

J Immunol. 2009 Jun 15;182(12):7440-50. doi: 10.4049/jimmunol.0900233.

13.

The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes.

Malizia G, Trejdosiewicz LK, Wood GM, Howdle PD, Janossy G, Losowsky MS.

Clin Exp Immunol. 1985 May;60(2):437-46.

14.

Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.

Ortiz-Sánchez JP, Cabrera-Chávez F, de la Barca AM.

Nutrients. 2013 Oct 21;5(10):4174-83. doi: 10.3390/nu5104174. Review.

15.

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes.

Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, Beri R, Dolcino M, Valletta E, Corrocher R, Puccetti A.

PLoS Med. 2006 Sep;3(9):e358.

16.

Repertoire of gluten peptides active in celiac disease patients: perspectives for translational therapeutic applications.

Camarca A, Del Mastro A, Gianfrani C.

Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):207-19. Review.

PMID:
22385112
17.

Changing phenotype of celiac disease after long-term gluten exposure.

Kurppa K, Koskinen O, Collin P, Mäki M, Reunala T, Kaukinen K.

J Pediatr Gastroenterol Nutr. 2008 Oct;47(4):500-3. doi: 10.1097/MPG.0b013e31817d8120. No abstract available.

PMID:
18852644
18.

[Immunology of celiac disease].

Arranz E, Garrote JA.

Gastroenterol Hepatol. 2010 Nov;33(9):643-51. doi: 10.1016/j.gastrohep.2009.11.003. Epub 2010 Feb 2. Spanish.

PMID:
20129704
20.

Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report.

Barera G, Bazzigaluppi E, Viscardi M, Renzetti F, Bianchi C, Chiumello G, Bosi E.

Pediatrics. 2001 Jun;107(6):E93.

PMID:
11389291

Supplemental Content

Support Center